NIH-funded research R01 grant

Impact of fasting on intestinal stem cells and cancer (policy: patient-facing)

Official title: Impact of fasting on intestinal stem cells and cancer

Funded at Massachusetts Institute of Technology · NIH-11367109 · Data updated 2026-11-12

This grant explores how fasting and refeeding affect gut stem cells and colorectal cancer risk in mouse and organoid models, with potential implications for people concerned about gut health and cancer risk.

More Fasting research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts Institute of Technology
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 1, 2020
Project endJuly 31, 2031
Funding year2026
Award (this year)$431,624
NIH project number2R01CA245314-06
Project IDNIH-11367109 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are individuals at risk for colorectal cancer or those interested in gut health and nutrition, though this project uses animal and organoid models.

Less likely to help

Direct patient benefit cannot be guaranteed; findings are in preclinical models and may take time to translate to people.

What this research studies

This research looks at how cycles of fasting followed by eating influence the cells in the intestine that repair the gut, and how these changes might affect early tumor development. Using mouse models and organoid systems, researchers will study polyamine metabolism and amino acids like proline to understand how these dietary cycles can both improve regeneration and, in some contexts, raise cancer risk. The team plans to test whether targeting polyamine pathways during fasting-refeeding can reduce cancer initiation and progression in preclinical models. Findings may guide future dietary or metabolic strategies to support gut health while minimizing cancer risk.

Why it matters

Potential benefit: If successful, the work could inform dietary approaches or metabolic targets to promote gut repair while reducing colorectal cancer risk.

How similar studies have gone: Prior studies show that fasting can boost tissue regeneration, but its impact on cancer risk is complex and still being explored.

Where this research is happening

  • Massachusetts Institute of Technology
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Yilmaz, Omer — Massachusetts Institute of Technology
  • Study coordinator: Yilmaz, Omer

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.